155 related articles for article (PubMed ID: 15081876)
1. Immunohistochemical detection of melphalan-DNA adducts in colon cancer cells in vitro and human colorectal liver tumours in vivo.
Rothbarth J; Koevoets C; Tollenaar RA; Tilby MJ; van de Velde CJ; Mulder GJ; Kuppen PJ
Biochem Pharmacol; 2004 May; 67(9):1771-8. PubMed ID: 15081876
[TBL] [Abstract][Full Text] [Related]
2. In vivo isolated kidney perfusion with tumour necrosis factor alpha (TNF-alpha) in tumour-bearing rats.
van der Veen AH; Seynhaeve AL; Breurs J; Nooijen PT; Marquet RL; Eggermont AM
Br J Cancer; 1999 Feb; 79(3-4):433-9. PubMed ID: 10027309
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of melphalan, oxaliplatin, and paclitaxel in colon, liver, and gastric cancer cell lines in a short-term exposure model of chemosaturation therapy by percutaneous hepatic perfusion.
Uzgare RP; Sheets TP; Johnston DS
Anticancer Res; 2013 May; 33(5):1989-2000. PubMed ID: 23645748
[TBL] [Abstract][Full Text] [Related]
4. Reduced liver uptake of arterially infused melphalan during retrograde rat liver perfusion with unaffected liver tumor uptake.
Rothbarth J; Sparidans RW; Beijnen JH; Schultze-Kool LJ; Putter H; van de Velde CJ; Mulder GJ
J Pharmacol Exp Ther; 2002 Nov; 303(2):736-40. PubMed ID: 12388659
[TBL] [Abstract][Full Text] [Related]
5. DNA adducts in normal colonic mucosa from healthy controls and patients with colon polyps and colorectal carcinomas.
Jonsson C; Stål P; Sjöqvist U; Akerlund JE; Löfberg R; Möller L
Mutagenesis; 2010 Sep; 25(5):499-504. PubMed ID: 20551081
[TBL] [Abstract][Full Text] [Related]
6. Immunological detection of DNA damage caused by melphalan using monoclonal antibodies.
Tilby MJ; Styles JM; Dean CJ
Cancer Res; 1987 Mar; 47(6):1542-6. PubMed ID: 3815354
[TBL] [Abstract][Full Text] [Related]
7. Hepatic artery infusion of high-dose melphalan at reduced flow during isolated hepatic perfusion for the treatment of colorectal metastases confined to the liver: a clinical and pharmacologic evaluation.
van Iersel LB; Verlaan MR; Vahrmeijer AL; van Persijn van Meerten EL; Tijl FG; Sparidans RW; Gelderblom H; Kuppen PJ; Tollenaar RA; van de Velde CJ
Eur J Surg Oncol; 2007 Sep; 33(7):874-81. PubMed ID: 17400422
[TBL] [Abstract][Full Text] [Related]
8. Tumour endothelial marker 8 (TEM-8) in human colon cancer and its association with tumour progression.
Rmali KA; Watkins G; Harrison G; Parr C; Puntis MC; Jiang WG
Eur J Surg Oncol; 2004 Nov; 30(9):948-53. PubMed ID: 15498639
[TBL] [Abstract][Full Text] [Related]
9. A monofunctional derivative of melphalan: preparation, DNA alkylation products, and determination of the specificity of monoclonal antibodies that recognize melphalan-DNA adducts.
Tilby MJ; McCartney H; Gould KA; O'Hare CC; Hartley JA; Hall AG; Golding BT; Lawley PD
Chem Res Toxicol; 1998 Oct; 11(10):1162-8. PubMed ID: 9778312
[TBL] [Abstract][Full Text] [Related]
10. First results of a quantitative study of DNA adducts of melphalan in the rat by isotope dilution mass spectrometry using capillary liquid chromatography coupled to electrospray tandem mass spectrometry.
Van den Driessche B; Esmans EL; Van der Linden A; Van Dongen W; Schaerlaken E; Lemière F; Witters E; Berneman Z
Rapid Commun Mass Spectrom; 2005; 19(14):1999-2004. PubMed ID: 15954175
[TBL] [Abstract][Full Text] [Related]
11. p53 elevation in relation to levels and cytotoxicity of mono- and bifunctional melphalan-DNA adducts.
Gould KA; Nixon C; Tilby MJ
Mol Pharmacol; 2004 Nov; 66(5):1301-9. PubMed ID: 15308759
[TBL] [Abstract][Full Text] [Related]
12. Gene-specific formation and repair of DNA monoadducts and interstrand cross-links after therapeutic exposure to nitrogen mustards.
Souliotis VL; Dimopoulos MA; Sfikakis PP
Clin Cancer Res; 2003 Oct; 9(12):4465-74. PubMed ID: 14555520
[TBL] [Abstract][Full Text] [Related]
13. Implementation of data-dependent acquisitions in the study of melphalan DNA adducts by miniaturized liquid chromatography coupled to electrospray tandem mass spectrometry.
Van den Driessche B; Van Dongen W; Lemière F; Esmans EL
Rapid Commun Mass Spectrom; 2004; 18(17):2001-7. PubMed ID: 15329868
[TBL] [Abstract][Full Text] [Related]
14. Induction and removal of cisplatin-DNA adducts in human cells in vivo and in vitro as measured by immunochemical techniques.
Fichtinger-Schepman AM; Dijt FJ; Bedford P; van Oosterom AT; Hill BT; Berends F
IARC Sci Publ; 1988; (89):321-8. PubMed ID: 3198216
[TBL] [Abstract][Full Text] [Related]
15. Synergistic antitumor activity of histamine plus melphalan in isolated limb perfusion: preclinical studies.
Brunstein F; Hoving S; Seynhaeve AL; van Tiel ST; Guetens G; de Bruijn EA; Eggermont AM; ten Hagen TL
J Natl Cancer Inst; 2004 Nov; 96(21):1603-10. PubMed ID: 15523089
[TBL] [Abstract][Full Text] [Related]
16. [Relationship between sensitivity of tumor cells to chemotherapeutic agent in vivo and in vitro: experiment with mouse lymphoma cells].
Li CG; Li ML; Shu XH; Jia YJ; Liu YJ; Li M
Zhonghua Yi Xue Za Zhi; 2007 Jun; 87(22):1576-8. PubMed ID: 17785116
[TBL] [Abstract][Full Text] [Related]
17. Patterns of heat shock protein (HSP70) expression and Kupffer cell activity following thermal ablation of liver and colorectal liver metastases.
Nikfarjam M; Muralidharan V; Su K; Malcontenti-Wilson C; Christophi C
Int J Hyperthermia; 2005 Jun; 21(4):319-32. PubMed ID: 16019858
[TBL] [Abstract][Full Text] [Related]
18. Novel amidine analogue of melphalan as a specific multifunctional inhibitor of growth and metabolism of human breast cancer cells.
Bielawski K; Bielawska A; Sosnowska K; Miltyk W; Winnicka K; Pałka J
Biochem Pharmacol; 2006 Jul; 72(3):320-31. PubMed ID: 16730667
[TBL] [Abstract][Full Text] [Related]
19. Implications of enzymatic, acidic and thermal hydrolysis of DNA on the occurrence of cross-linked melphalan DNA adducts.
Van den Driessche B; Lemière F; Witters E; Van Dongen W; Esmans EL
Rapid Commun Mass Spectrom; 2005; 19(4):449-54. PubMed ID: 15655794
[TBL] [Abstract][Full Text] [Related]
20. Chemopotentiating effects of a novel NAD biosynthesis inhibitor, FK866, in combination with antineoplastic agents.
Pogrebniak A; Schemainda I; Azzam K; Pelka-Fleischer R; Nüssler V; Hasmann M
Eur J Med Res; 2006 Aug; 11(8):313-21. PubMed ID: 17052966
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
